Gulf War Illness (GWI) is a chronic, multi-symptom condition affecting veterans of the 1990-1991 Gulf War. Those affected experience a wide range of symptoms, including fatigue, cognitive difficulties, chronic pain, and gastrointestinal issues. 

Despite decades of research, GWI remains complex and difficult to diagnose, with multiple potential causes linked to environmental exposures during deployment.

In this article, we’ll explore what Gulf War Illness is and its symptoms. We’ll also discuss the latest scientific research on GWI and emerging treatment approaches, including the role of photobiomodulation (PBM) as a potential tool for Brain wellness and symptom relief.

What Is Gulf War Illness?

As mentioned in the introduction, Gulf War Illness (GWI) is a chronic, multi-symptom condition affecting veterans of the 1990-1991 Gulf War. It encompasses a variety of symptoms, such as:

• Fatigue
• Headaches
• Joint pain
• Memory problems
• Digestive issues

While the exact cause of GWI is still unclear, it is believed to be related to exposure to toxic substances, vaccines, and environmental hazards during deployment. Because symptoms can vary widely from person to person, diagnosing and treating GWI can be challenging.

Common Symptoms of Gulf War Illness

Veterans with Gulf War Illness (GWI) experience a broad range of symptoms that can vary in severity. These symptoms often affect multiple areas of health, making GWI a complex condition to manage.

Below are the most common symptoms experienced by those with GWI, categorized for clarity:

• Neurological & Cognitive Issues: Brain fog, memory problems, difficulty concentrating.
• Chronic Fatigue & Pain: Persistent tiredness, muscle and joint pain.
• Headaches & Sensory Sensitivities: Severe headaches, sensitivity to light and sound.
• Gastrointestinal Problems: Digestive issues, irritable bowel syndrome (IBS).
• Respiratory & Immune System Dysfunction: Breathing difficulties, increased susceptibility to infections.

Given the wide variety of symptoms and their overlapping nature, understanding GWI requires a closer look at what it means to have a multi-symptom illness.

What Is a Multi-Symptom Illness?

A multi-symptom illness is a condition where multiple, often unrelated symptoms occur together, affecting different body parts. This makes diagnosing and treating these illnesses more complex, as doctors need to address a range of symptoms that may not have a clear connection.

Gulf War Illness (GWI) fits into this category, as its symptoms span across various systems in the body—neurological, muscular, gastrointestinal, and more. This wide range of symptoms can make it difficult to pinpoint a single cause or treatment. 

Additionally, the symptoms vary greatly from person to person, meaning no two cases of GWI are the same, further complicating the management of the illness.

Current Research and Treatment Approaches

Ongoing research into Gulf War Illness (GWI) has focused on potential links to neuroinflammation and mitochondrial dysfunction, which may explain the wide range of symptoms affecting veterans. 

In 2019, the Vielight Neuro Alpha was used in a successful pilot study by the University of California San Francisco on Gulf War Illness. This pilot study on US veterans represents the first documentation of GWI symptom improvements after PBM treatments.

Another particularly promising study, Transcranial Photobiomodulation to Improve Cognition in Gulf War Illness, investigated the use of red/near-infrared light therapy (photobiomodulation) applied to the brain. The results showed cognitive improvements, especially in veterans with higher PTSD symptoms, suggesting that this treatment could enhance brain function and reduce PTSD symptoms.

Current Treatment Options and Challenges

Currently, treatment strategies for GWI primarily focus on symptom management, including pain relief, cognitive therapy, and lifestyle changes. 

However, veterans often face significant challenges, such as limited treatment options, difficulty accessing care, and the need for more targeted, effective solutions. 

As GWI remains a complex condition, continued research and support are essential to develop more personalized and efficient treatments, helping affected veterans manage their symptoms and improve their quality of life.

Can Photobiomodulation (PBM) Help Veterans with GWI?

Photobiomodulation (PBM) is a non-invasive therapy that has gained attention for its potential to support Brain wellness and neurological function, particularly in conditions like Gulf War Illness (GWI). 

PBM uses red and near-infrared light to stimulate cells, which can help reduce inflammation, enhance cellular energy production, and promote neuroprotection. 

These effects are particularly relevant for GWI, as it is believed that neuroinflammation and mitochondrial dysfunction contribute to the condition’s symptoms.

Scientific interest in PBM has grown due to its success in treating conditions involving chronic pain, fatigue, and cognitive dysfunction—key issues for veterans with GWI. 

As researchers continue to explore PBM’s benefits, it shows promise as a potential tool to alleviate some of the debilitating symptoms of GWI, offering hope for improved symptom management and quality of life.

Vielight Neuro and Brain Regeneration: A New Era in Wellness

The Vielight Neuro series consists of research-backed, medical-grade photobiomodulation (PBM) devices designed to enhance cognitive function and support overall neurological health. Each one of them is designed to target specific brain functions:

• Vielight Neuro Duo offers both Gamma (40Hz) and Alpha (10Hz) pulse rates, allowing for mental energization and relaxation. Gamma waves are aimed at improving focus, memory, and brain energy, while Alpha waves promote relaxation and better sleep.
• Vielight Neuro Gamma focuses on enhancing brain energy, memory improvement, and cognitive focus through Gamma brain waves.
• Vielight Neuro Alpha targets the brain’s resting state, supporting mental coordination, mindfulness, and learning, often cited by athletes for achieving a “flow” state.
• Vielight Neuro Duo with Vagus System combines the benefits of the Duo model with non-invasive vagus nerve stimulation (VNS) via PBM, enhancing brain-body connectivity, improving mental clarity, reducing stress, and promoting overall well-being.

Utilizing Vielight’s patented intranasal PBM technology, these devices deliver near-infrared light to brain areas associated with memory, cognitive clarity, and neuroprotection. 

This innovative technology helps to stimulate brain cells, reduce inflammation, and improve cellular energy production, which is crucial for supporting cognitive health and combating conditions like Gulf War Illness (GWI).

With its focus on scientific research and practical solutions, Vielight aims to offer an effective, non-invasive treatment option to support neurological regeneration and improve the quality of life for individuals affected by cognitive decline and related conditions.

Unlock the power of your brain’s potential with Vielight—your path to a healthier, sharper future.

Is Photobiomodulation a Regenerative Medicine?

Regenerative medicine aims to restore damaged tissues and organs by stimulating the body’s natural healing processes. 

While treatments like stem cell therapy and tissue engineering are well known in this field, emerging technologies such as photobiomodulation (PBM) are gaining attention for their potential role in regeneration, particularly in Brain wellness and neurological recovery.

But is photobiomodulation a regenerative medicine? This article will explore PBM’s mechanisms, its ability to support cellular repair, and how it aligns with regenerative medicine principles. Read on to discover its potential benefits!

What Is Regenerative Medicine?

Regenerative medicine is a field of healthcare focused on restoring damaged tissues and organs by stimulating the body’s natural healing abilities. It aims to repair, replace, or regenerate cells, offering innovative solutions for conditions that traditional treatments may not fully address.

By leveraging biological mechanisms, regenerative medicine seeks to enhance recovery and improve long-term health outcomes. Its applications range from treating injuries and neurodegenerative diseases to promoting overall tissue regeneration and functional restoration.

Common Approaches in Regenerative Medicine

Regenerative medicine encompasses a variety of innovative approaches aimed at restoring function and promoting healing at a cellular level. 

Here are some of the most common strategies driving progress in this field.

• Stem Cell Therapy – Uses stem cells to replace damaged tissues and promote regeneration.
• Tissue Engineering – Combines biomaterials and cells to create functional tissues for medical use.
• Biologics – Includes growth factors, proteins, and gene therapies to accelerate tissue repair and healing.

Could photobiomodulation be the next breakthrough in regenerative medicine? Let’s explore how it works.

How Photobiomodulation (PBM) Works

Photobiomodulation (PBM) is a non-invasive therapy that uses specific wavelengths of light to stimulate biological processes at the cellular level. When light penetrates the skin and reaches targeted tissues, it interacts with mitochondria—the energy centers of cells—enhancing their ability to produce ATP (adenosine triphosphate), the fuel necessary for cellular function and repair.

PBM plays a fundamental role in cellular repair and regeneration by boosting mitochondrial activity. It helps reduce oxidative stress and inflammation, two key factors in tissue damage and aging. 

Additionally, PBM has been shown to enhance neuroplasticity, improve circulation, and accelerate recovery, making it a promising tool in regenerative medicine, particularly for Brain wellness and neurological conditions.

Can PBM Be Considered Regenerative Medicine?

Research suggests that photobiomodulation (PBM) has significant potential in regenerative medicine, particularly for neurological conditions. 

Studies have shown that PBM may aid in stroke recovery by reducing inflammation and promoting cellular repair. Additionally, PBM has been linked to improvements in neurodegenerative diseases like Alzheimer’s and Parkinson’s, helping to enhance cognitive function and slow disease progression. 

Scientific findings further support PBM’s role in neuroprotection and tissue repair. 

A 2022 study published in Frontiers in Medical Technology (Near-Infrared Photobiomodulation of Living Cells, Tubulin, and Microtubules In Vitro) demonstrated that PBM influences cellular structures, promotes microtubule reorganization, and balances neural activity, key factors in brain regeneration. 

These findings reinforce the idea that PBM can help maintain Brain wellness, repair damaged neural networks, and enhance overall cognitive function.

Benefits of PBM in Regenerative Medicine

Photobiomodulation (PBM) is emerging as a powerful tool in regenerative medicine, offering a non-invasive approach to supporting tissue repair and Brain wellness. By stimulating cellular activity with near-infrared light, PBM helps improve cognitive function, accelerate recovery, and promote overall well-being. 

Here are some key benefits:

• Improved Brain wellness and Neuroplasticity: PBM enhances cognitive function and mental clarity by promoting neuroplasticity—the brain’s ability to reorganize and form new connections. This can be beneficial for individuals recovering from neurological conditions or looking to optimize brain performance.
• Enhanced Recovery from Injury: PBM helps reduce inflammation and oxidative stress, two major barriers to healing. By stimulating mitochondrial activity, it accelerates cellular repair, making it useful for recovery after brain injuries, strokes, or neurodegenerative conditions.
• Non-Invasive and Safe Alternative: Unlike many regenerative therapies that require surgery or drug treatments, PBM offers a safe, non-invasive solution with minimal risks. It provides a scientifically backed way to support regeneration without the need for complex medical interventions.

Photobiomodulation’s potential in regenerative medicine is clear, but how can you integrate this groundbreaking technology into daily life? That’s where Vielight Neuro comes in.

Vielight Neuro: Bringing Regenerative Benefits to Everyday Life

As photobiomodulation (PBM) continues to gain recognition in regenerative medicine, Vielight Neuro stands at the forefront of innovation. Recognized as the world’s most researched brain PBM device, it’s designed to enhance cognitive function, neuroplasticity, and overall Brain wellness through cutting-edge technology.

With its medical-grade design and research-backed efficacy, Vielight Neuro makes advanced brain regeneration accessible for everyday use. 

Explore how PBM technology can help optimize your Brain wellness and bring the benefits of regenerative medicine into your daily life. Schedule a free video consultation with one of our experts to get your questions answered.

Chronic traumatic encephalopathy (CTE) is a degenerative brain disease that is believed to result from repeated head injuries, particularly concussions. It is commonly associated with contact sports such as football, hockey, boxing, and rugby, but can also occur in other activities that involve repeated blows to the head.

CTE is characterized by the accumulation of an abnormal protein called tau in the brain. Tau forms clumps, known as neurofibrillary tangles, which gradually spread and cause damage to brain cells over time. This damage can lead to various cognitive, behavioral, and mood-related symptoms.

The symptoms of CTE can include memory loss, confusion, impaired judgment, aggression, depression, anxiety, impulse control problems, and eventually progressive dementia. However, the diagnosis of CTE can only be definitively made after death by examining the brain tissue under a microscope.

Intro

Dr Margaret Naeser from the Department of Neurology, Boston University School of Medicine, led a case-series study on the effects of brain photobiomodulation on former athletes with TBI and possible CTE.

This study features two components:

• In-office treatments (3x a week, 6 weeks)
• At-home treatments

Aims of Study

The primary aim was to present post-tPBM changes in cognition and behavior/mood for four, American-style ex-football players who had progressive symptoms of TES, possible CTE. The secondary aim was to present post-tPBM changes on MRI, including rs-fcMRI (SN, CEN, DMN), and magnetic resonance spectroscopy (MRS) for metabolites in cingulate cortex.

This study was approved by the Institutional Review Board, VA Boston Healthcare System. The MRI scan portion was approved by the IRB, Boston University School of Medicine where MRI scans were performed. Participants signed Informed Consent Forms; all methods were performed in accordance with relevant guidelines and regulations. This was an open-protocol, pilot study.

• Initial, in-office tPBM series

Each participant received an initial, in-office tPBM treatment series. This included 18 tLED treatments, each lasting approximately 22–40 min (3x/week, 6 weeks), with 48 h between treatments.

Three different tPBM devices/protocols were used. This is due to availability of more advanced devices, as the pilot study progressed. Common characteristics across all devices included application of NIR wavelengths (810 nm, 850 nm, or 870 nm) to scalp locations.

Case P1

P1 entered at age 65, with AFE to football at age 10. He played middle linebacker, defense position for 14 years including 1.5 years in the Canadian Football League. He received two tPBM treatment series, e.g., initial, in-office, and later, at-home.

Results

In-Office tPBM treatments

At 1 week and 1 month after the final, 18th In-office treatment (compared to pre-treatment), P1 showed significant improvement on five tests/subtests: 1) CVLT for 16 words to remember: Short Delay Cued Recall; 2) and 3), Continuous Performance Test (CPT): decreased False Alarm Rate, and improved d prime, detectability; 4) and 5), Brief Visuospatial Memory Test (BVMT): Immediate Recall, and Recognition Discrimination Index (Recognition Hits minus False Alarms).

Behavior/mood questionnaires: Lower ratings indicate less impairment.

At the 2-months post-testing, however, there was decline, with significant improvement remaining only on one subtest, the BVMT, Recognition Discrimination Index. At the 2-months post-testing visit, P1 mentioned that return of emotional outbursts and depression was disturbing.

Within one week, he obtained a Vielight Neuro Gamma for at-home, self-treatment.

Case P2

P2 entered at age 55, with AFE to football at age 7. He played offensive lineman, tackle position for 15 years through college only. He received two tPBM series, initial, in-office, and later, at-home.

In-Office tPBM treatments

P2 was initially treated with a tPBM helmet, lined with red/NIR LED cluster heads.

Results: Initial, in-office tPBM series

NP tests: At 1 week or 6 weeks after the final, 18th in-office treatment (compared to pre-treatment), P2 showed significant improvement on six tests/subtests: 1)–4), CVLT four subtests: Total Trials 1–5; Short Delay, Cued Recall; Long Delay (20 min) Free Recall, and Cued Recall; 5), verbal fluency on COWAT; and 6) BVMT, Immediate Recall. At 12 weeks after the in-office series, five tests/subtests (CVLT) still showed significant improvement.

Behavior/mood questionnaires: At 1-week or 6-weeks post- the in-office tPBM series (compared to pre-treatment), improvements were present for PTSD/PCL-C, BDI, SF-MPQ, and DEX. At 12 weeks, however, there was an increase in PTSD/PCL-C, and some increased pain on the SF-MPQ rating to 9, the same as pre-treatment (Fig. 3B; Supplementary Table 4B).

At 12 weeks after the in-office series had ended, P2 was disturbed by return of emotional outbursts. One week later, he obtained his own tPBM devices for at-home, self-treatment.

Conclusions

Overall results are encouraging from this first, case-series report with four ex-football players meeting TES criteria for Possible CTE. Their cognitive and behavior/mood disturbances were well-managed and significantly improved following NIR tPBM treatments. To the authors’ knowledge, this is the first report of a potential treatment modality to mitigate symptoms of Possible CTE. Instead of continuing to worsen over time, these cases improved with tPBM. Without sham-control, a possible placebo effect is unknown. Significant correlations on rs-fcMRI with increased SN FC and improvements in executive function, attention, PTSD, pain, and sleep; and increased CEN FC with verbal learning and memory, less depression; plus increased NAA in ACC on MRS along with less pain and PTSD, all support a beneficial effect from tPBM.